搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
20 小时
Annexon股份因ARCHER试验数据利好而上涨,分析师维持买入评级
ARCHER试验正在评估ANX007治疗地理性萎缩 (GA)的效果,GA是一种可导致视力丧失的晚期年龄相关性黄斑变性。据分析师称,最新的数据分析为相信ANX007是GA的有效治疗方法提供了进一步的依据。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Workers reject new contract
Settles civil lawsuit
NK troops in RU confirmed
Joins Republican Party
Suffers 'debilitating' stroke
Yelp disables reviews
Courthouse attack charges
Dodgers legend dies
Biden says lock up Trump
To close 150 locations
MO court upholds release
'Tarzan' star Ron Ely dies
First father-son duo in NBA
Apple, Goldman Sachs fined
DOJ alleges racial bias
Bird flu infects 4 in WA
Lake Erie toxic algae study
Timberlake postpones shows
DNC office shootings arrest
Hashem Safieddine killed
Closing argument speech plan
FDA recalls antidepressant
Israel strikes Lebanese city
Kentucky lawmaker dies
G7 Ukraine loan advances
Court orders new sentence
Existing home sales fall
Settles hazardous waste suit
$3.9B storm relief proposal
反馈